July 26, 2017 11:49 PM ET

Biotechnology

Company Overview of Accera, Inc.

Company Overview

Accera, Inc. is a clinical stage biotechnology company that develops therapies for central nervous system disorders. The company focuses on developing a pipeline of products targeting neurodegenerative conditions. Its proprietary scientific platform addresses unmet medical needs in brain health, including Alzheimer’s disease. The company was founded in 2001 and is based in Boulder, Colorado.

3005 Center Green Drive

Suite 205

Boulder, CO 80301

United States

Founded in 2001

Phone:

303-999-3700

Fax:

303-999-3799

Key Executives for Accera, Inc.

Chief Executive Officer and President
Founder
Age: 61
Chief Financial Officer
Age: 57
Chief Medical Officer
Vice President of Finance, Controller and Secretary
Compensation as of Fiscal Year 2017.

Accera, Inc. Key Developments

Accera Enters into Strategic Partnership and Exclusive Licensing Agreement with DuChemBio for Accera's Technology in Korea

Accera, Inc. and DuChemBio Co. Ltd. announced that the companies have entered into a strategic partnership and exclusive licensing agreement whereby DuChemBio will obtain rights to develop, obtain regulatory approval and commercialize products in South Korea using Accera's medium chain triglyceride technology.

Accera, Inc. Presents at 12th Annual Neurotech Investing and Partnering Conference, Jun-01-2017 02:30 PM

Accera, Inc. Presents at 12th Annual Neurotech Investing and Partnering Conference, Jun-01-2017 02:30 PM. Venue: Park Central Hotel, San Francisco, California, United States. Speakers: Charles Stacey, Chief Executive Officer and President.

Accera, Inc. Presents at BIO International Conference 2017, Jun-20-2017 03:00 PM

Accera, Inc. Presents at BIO International Conference 2017, Jun-20-2017 03:00 PM. Venue: San Diego Convention Center, San Diego, CA 2865, United States. Speakers: Charles Stacey, Chief Executive Officer and President.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Accera, Inc., please visit www.accerapharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.